Complement C2 deficiency disarranging innate and adaptive humoral immune responses in a pediatric patient: treatment with rituximab.
Hauck
Fabian
F
University Medical Center Carl-Gustav-Carus, Technical University, Dresden, Germany. fabian.hauck@inserm.fr
Lee-kirsch
Min Ae
MA
Aust
Daniela
D
Roesler
Joachim
J
Pessler
Frank
F
D056704:Adaptive Immunity / Q000187:drug effects*; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology; D001706:Biopsy; D002675:Child, Preschool; D003175:Complement C2 / Q000172:deficiency*; D005260:Female; D006801:Humans; D056724:Immunity, Humoral / Q000187:drug effects*; D007113:Immunity, Innate / Q000187:drug effects*; D007150:Immunohistochemistry; D007153:Immunologic Deficiency Syndromes / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D007155:Immunologic Factors / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D000069283:Rituximab; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D058846:Antibodies, Monoclonal, Murine-Derived; D003175:Complement C2; D007155:Immunologic Factors; D000069283:Rituximab